Highlights
NASDAQ: KIN       Kindred Biosciences
Last Price Today's Change   Day's Range   Trading Volume
5.29   +0.40 (8.18%)  4.81 - 5.34  399,995

Overview

 
Avg Volume (4 weeks):459,131
4 Weeks Range:3.72 - 5.44
4 Weeks Price Volatility (%):
91.28%
52 Weeks Range:3.105 - 11.93
52 Weeks Price Volatility (%):
24.76%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Kindred Biosciences Inc is a US-based development-stage biopharmaceutical company which focuses on developing medicines for pets. Its lead products candidates are the intravenous (IV) form of Zimeta which is a dipyrone injection for the control of pyrexia in horses and Mirataz which is a mirtazapine transdermal ointment for the management of weight loss in cats. The product pipeline of the company consists of small molecules and biologics for a range of indications in dogs, cats, and horses, with focus near-term on equine small molecule products and canine and feline biologics products.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2010  3947  233  3092 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AAPL 106.84-3.50 
 LK 1.38+1.38 
 KODK 12.11+1.41 
 ONTX 0.322+0.072 
 GE 6.88-0.17 
 SAVA 10.07+2.98 
 SQQQ 27.48+1.06 
 WFC 25.13+0.02 
 TSLA 442.15+18.72 
 RIG 1.06-0.05 
PARTNERS & BROKERS